Buprenorphine And Naloxone Tablet
Product Images NDC 0228-3155

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0228-3155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Round Tablets (Image 1)

Round Tablets (Image 1)
FDA Label Image

The Following Chemical Structure Of Buprenorphine HCl, Usp Has The Molecular Formula C29h41no4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol, And Practically Insoluble In Cyclohexane. (Image 2)

The Following Chemical Structure Of Buprenorphine HCl, Usp Has The Molecular Formula C29h41no4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly Soluble In Water, Freely Soluble In Methanol, Soluble In Alcohol, And Practically Insoluble In Cyclohexane. (Image 2)
FDA Label Image

The Following Chemical Structure Of Naloxone Hydrochloride Dihydrate, Usp Has The Molecular Formula C19h21no4 • HCl • 2h2o And The Molecular Weight Is 399.87. It Is A White To Slightly Off-white Powder And Is Freely Soluble In Water, Soluble In Alcohol, And Practically Insoluble In Toluene And Ether. (Image 3)

The Following Chemical Structure Of Naloxone Hydrochloride Dihydrate, Usp Has The Molecular Formula C19h21no4 • HCl • 2h2o And The Molecular Weight Is 399.87. It Is A White To Slightly Off-white Powder And Is Freely Soluble In Water, Soluble In Alcohol, And Practically Insoluble In Toluene And Ether. (Image 3)
FDA Label Image

Round Tablet (Image 4)

Round Tablet (Image 4)
FDA Label Image

Round Tablet (Image 5)

Round Tablet (Image 5)
FDA Label Image

2 (Image 6)

2 (Image 6)
FDA Label Image

1 (Image 7)

1 (Image 7)
This text appears to be a medication label for Buprenorphine and Naloxone sublingual tablets. It includes information such as the drug's unique identification number, dosage, and storage instructions. It also emphasizes to keep the medication out of reach of children, as accidental ingestion could lead to the need for emergency medical care.*
FDA Label Image

1 (Image 8)

1 (Image 8)
This is a medication with the NDC code 0228-3155-03 consisting of buprenorphine and naloxone tablets to treat opioid dependence. It has specific guidelines on the dosage and administration, and should be dispensed in light-resistant containers. Additionally, it needs to be kept out of the reach of children. This particular product has 30 tablets and was manufactured for Teva Pharmaceuticals, with a product code of 52-0487.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.